ASLAN Pharmaceuticals Limited revenue for the last year amounted to 12.00 M USD, the most of which — 12.00 M USD — came from its highest performing source at the moment, Cancer Novel Drugs, the year earlier bringing 2.99 M USD. The greatest contribution to the revenue figure was made by Japan — last year it brought ASLAN Pharmaceuticals Limited 12.00 M USD.